CTRI/2021/03/031985尚未招募1 期
A Pilot Study To Compare Bioavailability Between Wockhardtâ??s Wosulin® N (100 IU/mL) {Isophane Insulin Human, suspension, r- DNA origin} a nd Humulin N (100 IU/mL), In Healthy Male Subjects.
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Ba/be
入排标准
入选标准
- •Subjects with normal health as determined by medical history, clinical examination and laboratory examinations within the clinically acceptable normal range.
排除标准
- •- Hypersensitivity to Insulin or related class of drugs.
- •- History or presence of significant cardiovascular, pulmonary, hepatic, renal, gastrointestinal, endocrine, immunological, dermatological, neurological or psychiatric disease or disorder.
研究者
相似试验
已完成
1 期
BA-BE study for WOCKHARDTâ??SWOSULIN® N AND HUMULINCTRI/2020/06/026261Wockhardt Ltd14
已完成
1 期
A phase I study to compare the bioavailability and pharmacokinetics of fentanyl after administration of a single dose of a Fentanyl MDTS and a Durogesic 25 patch in paiPainOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12605000526673Acrux DDS Pty Ltd6
已完成
1 期
Bio-availability study of Wosulin® 30/70CTRI/2020/06/026146Wockhardt Ltd14
尚未招募
1 期
Bio-availability trial of Wosulin® 30/70CTRI/2019/07/020383Wockhardt Bio AG
已完成
Unknown
Absorption and availability of NCT023 extract in blood in healthy volunteersCTRI/2023/10/058565isarga Biotech Pvt. Ltd.14